MedX Health Corp. announced the signing of a commercial distribution agreement with Makromed/Arhan Global A.S following the conclusion of its successful paid pilot project. In conjunction with signing the agreement, Makromed has committed to an initial 60-unit order for 2022, with an immediate order of 40 units and an option for 20 more units to be confirmed by October 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.09 CAD | +5.88% | +12.50% | +50.00% |
31/05 | MedX Health Corp. Brief: Announced Proposed Extension of Non-brokered Private Placement Offering | MT |
30/05 | MedX Health Corp Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+50.00% | 17.25M | |
+9.24% | 221B | |
+15.84% | 198B | |
+23.95% | 148B | |
+31.67% | 112B | |
+4.68% | 66.85B | |
+14.99% | 52.84B | |
+4.85% | 50.86B | |
-4.47% | 38.75B | |
-0.41% | 35.15B |
- Stock Market
- Equities
- MDX Stock
- News MedX Health Corp
- Medx Health Corp. Signs Commercial Distribution Agreement with Makromed/Arhan Global A.S to Launch Medx's Teledermatology Screening Platform in Turkey